281 related articles for article (PubMed ID: 25799800)
1. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
Shrestha S; Jha AK; Thapa DP; Bhattarai CK; Ghimire A
Nepal Med Coll J; 2014 Sep; 16(1):1-4. PubMed ID: 25799800
[TBL] [Abstract][Full Text] [Related]
2. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo.
Köse O; Arca E; Kurumlu Z
J Dermatolog Treat; 2010 May; 21(3):133-9. PubMed ID: 20394489
[TBL] [Abstract][Full Text] [Related]
3. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
Majid I
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
[TBL] [Abstract][Full Text] [Related]
6. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus.
Taher ZA; Lauzon G; Maguiness S; Dytoc MT
Br J Dermatol; 2009 Sep; 161(3):654-9. PubMed ID: 19438859
[TBL] [Abstract][Full Text] [Related]
7. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
8. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
11. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
12. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
Hartmann A; Bröcker EB; Hamm H
Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
[TBL] [Abstract][Full Text] [Related]
13. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study.
Katsarou A; Makris M; Papagiannaki K; Lagogianni E; Tagka A; Kalogeromitros D
Eur J Dermatol; 2012; 22(2):192-6. PubMed ID: 22407003
[TBL] [Abstract][Full Text] [Related]
15. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
[TBL] [Abstract][Full Text] [Related]
16. Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus.
Gradman J; Wolthers OD
Acta Paediatr; 2007 Aug; 96(8):1233-7. PubMed ID: 17590198
[TBL] [Abstract][Full Text] [Related]
17. Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo.
Saldanha KD; Machado Filho CD; Paschoal FM
An Bras Dermatol; 2012; 87(5):685-90. PubMed ID: 23044558
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
Tanghetti EA
Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
Grimes PE; Morris R; Avaniss-Aghajani E; Soriano T; Meraz M; Metzger A
J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
Dayal S; Sahu P; Gupta N
Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
